Farmahemi B.V. (manufacturing of unpackaged product, primary and secondary packaging, batch control, batch release authorization)

The drug is used as a monotherapy or in combination with other antineoplastic agents for the treatment of epithelial ovarian cancer and small cell lung cancer.

Dosage form: concentrate for infusion solution

ATC: L01XA02